The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Lianhai ^a   Liu, Yiqiang ^a   Wang, Xiaohong ^a   Tang, Zhiyu ^a   Li, Shuangxi ^a   Hu, Ying ^a   Zong, Xianglong ^a   Wu, Xiaojiang ^a   Bu, Zhaode ^a   Wu, Aiwen ^a   Li, Ziyu ^a   Li, Zhongwu ^a   Huang, Xiaozheng ^a   Jia, Ling ^a   Kang, Qiang ^a   Liu, Yong ^b   Sutton, David ^b   Wang, Lai ^b   Luo, Lusong ^b   Ji, Jiafu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b BeiGene   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; PTPRC PROTEIN, HUMAN;

ANIMAL; B CELL LYMPHOMA; B LYMPHOCYTE; CARCINOGENESIS; DISEASE MODEL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; LYMPHOMA; MOUSE; NONOBESE DIABETIC MOUSE; PATHOGENICITY; PATHOLOGY; PROCEDURES; SCID MOUSE; VIROLOGY; XENOGRAFT;

ANIMALS; ANTIGENS, CD45; B-LYMPHOCYTES; CARCINOGENESIS; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFLAMMATION; LYMPHOMA; LYMPHOMA, B-CELL; MICE; MICE, INBRED NOD; MICE, SCID; TRANSPLANTATION, HETEROLOGOUS;

EID: 84925852656     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09447     Document Type: Article

References (21)

1. Marangoni, E. et al. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin. Cancer Res. 13, 3989-3998 (2007).
2. Nemati, F. et al. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin. Cancer Res. 16, 2352-2362 (2010).
3. Fichtner, I. et al. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin. Cancer Res. 14, 6456-6468 (2008).
4. Hennessey, P. T. et al. Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts. PLoS One 6, e20584 (2011).
5. Yang, M. et al. Overcoming erlotinib resistance with tailored treatment regimen in patient-derived xenografts from naive Asian NSCLC patients. Int. J. Cancer 132, E74-84 (2013).
6. Tentler, J. J. et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9, 338-350 (2012).
7. Decaudin, D. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer. Anticancer Drugs 22, 827-841 (2011).
8. Puig, I. et al. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res 19, 6787-6801 (2013).
9. Dodbiba, L. et al. Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment. Lab Invest 93, 397-407 (2013).
10. Dong, X. et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 16, 1442-1451 (2010).
11. Mosier, D. E. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv Immunol 50, 303-325 (1991).
12. Duchosal, M. A., Eming, S. A., McConahey, P. J. & Dixon, F. J. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease. Am J Pathol 141, 1097-1113 (1992).
13. Chen, K., Ahmed, S., Adeyi, O., Dick, J. E. & Ghanekar, A. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus. PLoS One 7, e39294 (2012).
14. John, T. et al. Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 7, 1101-1108 (2012).
15. Rezk, S. A. & Weiss, L. M. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38, 1293-1304 (2007).
16. Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20, 1161-1181 (1996).
17. Thompson, M. P. & Kurzrock, R. Epstein-Barr virus and cancer. Clin Cancer Res 10, 803-821 (2004).
18. Tarantul, V. Z. Virus-associated lymphomagenesis. Int J Biomed Sci 2, 101-113 (2006).
19. Epeldegui, M., Vendrame, E. & Martinez-Maza, O. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol Res 48, 72-83 (2010).
20. You, W. C. et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 98, 974-983 (2006).
21. Denkert, C. et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28, 105-113 (2010).